Showing results (151-160 of 182) with videos related to
Sort By:
Pageof 19
Molecules (Basel, Switzerland)|September 9, 2022
Improving the Thermal Behavior and Flame-Retardant Properties of Poly(o-anisidine)/MMT Nanocomposites Incorporated with Poly(o-anisidine) and Clay NanofillerMirza Nadeem Ahmad, Sohail Nadeem, Mohsin Javed, et al.Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase InhibitorAya Soudi, Onur Bender, Ismail Celik, et al.Frontiers in Chemistry|May 18, 2023
Transition metal doped CeO2 for photocatalytic removal of 2-chlorophenol in the exposure of indoor white light and antifungal activityM Tariq Qamar, Shahid Iqbal, M Aslam, et al.Plos One|January 30, 2023
New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studiesAhmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.Molecules (Basel, Switzerland)|May 14, 2022
External Electric Field Effect on the Strength of σ-Hole Interactions: A Theoretical Perspective in Like⋯Like Carbon-Containing ComplexesMahmoud A A Ibrahim, Nayra A M Moussa, Afnan A K Kamel, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 17, 2022
New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studiesEslam B Elkaeed, Mohammed S Taghour, Hazem A Mahdy, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|November 20, 2023
Novel N-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulationsHesham Haffez, Nosaiba A Elsayed, Marwa F Ahmed, et al.RSC Advances|August 7, 2023
Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2Souad A El-Metwally, Hazem Elkady, Mohamed Hagras, et al.International Journal of Pharmaceutics|December 15, 2021
Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosisWagdy M Eldehna, Mahmoud A El Hassab, Nahla A Abdelshafi, et al.Molecules (Basel, Switzerland)|October 14, 2022
Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation StudiesEslam B Elkaeed, Reda G Yousef, Mohamed M Khalifa, et al.Pageof 19